State Hospital Feldkirch  - Start of another trial site in Austria

Today, the State Hospital Feldkirch in Austria became officially an active trial site of the STOP-PKD Study.

The team of Dr. Emanuel Zitt cares for patients with a wide range of nephrological issues, including those affected by autosomal dominant polycystic kidney disease (ADPKD).

Interested patients can now make an appointment at the trial site in Feldkirch, Austria to obtain detailed information about the trial and potential participation.

Phone: +43 5522 303 2735 / +43 5522 303 2730 (Mo - Fr 11:00 - 12:00)

Email:   nephro@lkhf.at